首页> 外文期刊>Neurosurgery >Endovascular treatment of experimental aneurysms using a combination of thermoreversible gelation polymer and protection devices: feasibility study.
【24h】

Endovascular treatment of experimental aneurysms using a combination of thermoreversible gelation polymer and protection devices: feasibility study.

机译:使用热可逆凝胶聚合物和保护装置的组合对实验性动脉瘤进行血管内治疗:可行性研究。

获取原文
获取原文并翻译 | 示例
           

摘要

OBJECTIVE: We developed a new liquid embolic agent, an aqueous solution of thermoreversible gelation polymer (TGP) for the treatment of cerebral aneurysms. This polymer solution has the unique characteristics that allow it to solidify at a specific temperature without solvent. We performed an experimental aneurysm embolization using this liquid embolic agent with and without different protective devices to evaluate its technical feasibility for the treatment of aneurysms. METHODS: Fourteen side-wall aneurysms were surgically constructed on 14 common carotid arteries of 7 swine. Embolizations were conducted in combination with balloon protection (balloon group, n = 4), microstent protection (stent group, n = 4), and microcoil and microstent protection (stent-coil group, n = 4). Two aneurysms were used as controls. One control aneurysm was not embolized, and the other received control stent placement only. Angiographic follow-up was performed on day 14 and was followed by histopathological evaluation. RESULTS: Successful TGP solution delivery was conducted in all cases. Complete aneurysm occlusion was achieved in all cases without TGP migration. Follow-up angiograms demonstrated complete occlusion in the stent and stent-coil groups. A small recurrence was observed in the balloon group. Histopathological findings demonstrated neoendothelialization across the necks of the aneurysms. CONCLUSION: Experimental aneurysms were safely embolized using TGP. Further modifications related to mechanical stability and long-term safety evaluation results are necessary before clinical application.
机译:目的:我们开发了一种新型的液体栓塞剂,一种可逆性凝胶聚合物(TGP)的​​水溶液,用于治疗脑动脉瘤。该聚合物溶液具有独特的特性,可以在没有溶剂的情况下在特定温度下固化。我们使用这种液体栓塞剂在有无保护装置的情况下进行了实验性动脉瘤栓塞,以评估其在治疗动脉瘤方面的技术可行性。方法:在7头猪的14条颈总动脉上通过外科手术构造了14个侧壁动脉瘤。栓塞结合气囊保护(气球组,n = 4),微支架保护(支架组,n = 4),微线圈和微支架保护(支架线圈组,n = 4)进行。使用两个动脉瘤作为对照。一个对照动脉瘤没有栓塞,另一个仅接受了对照支架放置。在第14天进行血管造影随访,然后进行组织病理学评估。结果:在所有情况下均成功进行了TGP解决方案交付。在没有TGP迁移的所有情况下都实现了完全的动脉瘤闭塞。后续血管造影显示支架和支架线圈组完全闭塞。气球组观察到少量复发。组织病理学检查结果表明,整个动脉瘤的颈部都出现了新内皮化。结论:TGP可安全栓塞实验性动脉瘤。在临床应用之前,需要对机械稳定性和长期安全性评估结果进行进一步修改。

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
获取原文

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号